The FibroScan-AST (FAST) score has been shown to be effective for the risk assessment of non-alcoholic hepatic steatosis (NASH) in patients without HIV, but its effectiveness in HIV+ patients is currently...
Certain biomarkers could be used to identify people living with HIV who are at increased risk of developing non-alcoholic fatty liver disease, according to recent research.
A new study presented during a late-breaking session at The Liver Meeting evaluated the safety and efficacy of oral seladelpar among more than 100 patients with primary biliary cholangitis.
Researchers evaluated data of more than 200 patients to see whether a thrombopoietin receptor agonist could serve as an alternative to blood transfusion in thrombocytopenia and chronic liver disease.
Researchers aimed to determine the prevalence and characteristics of nonalcoholic fatty liver disease in individuals with metabolically healthy obesity.
New data from the Drug-Induced Liver Injury Network prospective study helped clarify the relationship between alcohol consumption and idiosyncratic drug-induced liver injury.
Acetaminophen overdose is known to be the leading cause of acute liver injury and acute liver failure in developed countries. In a recent study, researchers investigated the sex differences of...
